Live Breaking News & Updates on Venebio Group

Stay updated with breaking news from Venebio group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin

Background Obesity is a serious disease that is associated with an increased risk of diabetes, hypertension, heart disease, stroke, and cancer, among other diseases. The United States Centers for Disease Control and Prevention (CDC) estimates a 20% obesity rate in the 50 states, with 12 states having rates of over 30%. Currently, the body mass index (BMI) is most commonly used to determine adiposity. However, BMI presents as an inaccurate obesity classification method that underestimates the epidemic and contributes to failed treatment. In this study, we examine the effectiveness of precise biomarkers and duel-energy x-ray absorptiometry (DXA) to help diagnose and treat obesity. Methodology/Principal Findings A cross-sectional study of adults with BMI, DXA, fasting leptin and insulin results were measured from 1998–2009. Of the participants, 63% were females, 37% were males, 75% white, with a mean age = 51.4 (SD = 14.2). Mean BMI was 27.3 (SD = 5.9) and mean percent body fat wa ....

United-states , Pakistan , Americans , American , Qamaruddin-nizami , Vemco-meded , Cerner-lifesciences , Glaxosmithkline , University-of-south-florida-medical-school , National-institute-of-health , Novartis , Robert-wood-johnson-foundation